Identification of the key genes and long non‑coding RNAs in ankylosing spondylitis using RNA sequencing Corrigendum in /10.3892/ijmm.2022.5154

Xu,Zhengkuan; Li,Hao; Chen,Qixin; Chen,Gang

doi:10.3892/ijmm.2018.4038

Identification of the key genes and long non‑coding RNAs in ankylosing spondylitis using RNA sequencing

Corrigendum in: /10.3892/ijmm.2022.5154

Authors:
- Zhengkuan Xu
- Hao Li
- Qixin Chen
- Gang Chen
View Affiliations

Affiliations: Department of Orthopedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China
Published online on: December 20, 2018 https://doi.org/10.3892/ijmm.2018.4038
Pages: 1179-1192
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ankylosing spondylitis (AS) is an insidious and debilitating form of arthritis that involves the axial skeleton, and its etiology and pathogenesis remain unclear. In the present study, three patients with AS and three normal controls from our hospital were enrolled. RNA sequencing and bioinformatics analysis were performed in order to identify the differentially expressed (DE) mRNAs (DEmRNAs) and DE long non‑coding RNAs (DElncRNAs) between the patients with AS and normal controls. Construction of an AS‑specific protein‑protein interaction network, a weighted DElncRNA‑DEmRNA co‑expression network and functional annotation of the DEmRNAs co‑expressed with DElncRNAs was performed. Nearby cis‑targeted DEmRNAs or DElncRNAs were identified by searching for DEmRNAs that were transcribed within 100‑kb up‑ or downstream of DElncRNAs. Based on the Gene Expression Omnibus datasets GSE25101 and GSE73754, the expression of selected DEmRNAs and DElncRNAs were verified using published RNA sequencing data from blood samples, and receiver operating characteristic analysis of selected DEmRNAs was performed. Compared with the normal controls, 1,072 DEmRNAs and 372 DElncRNAs in the patients with AS were identified. Caspase recruitment domain family member 11 and DNA methyltransferase 1 have great diagnostic value for AS. MSTRG.8559 and LINC00987 were also identified as two hub DElncRNAs. The T‑cell receptor signaling pathway was a significantly enriched pathway of the DEmRNAs co‑expressed with DElncRNAs in patients with AS. In conclusion, the present study identified the key DEmRNAs and DElncRNAs in AS, which provides novel information for understanding the pathogenesis of AS and developing potential biomarkers for AS.

View Figures

View References

1	Zhou L, Zhang Y, Xu H, Hu L, Zhang C, Sun L, Xie Y, Lu H, Zhang Z, Hu W and Lin X: Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis. Am J Med Sci. 349:488–492. 2015. View Article : Google Scholar : PubMed/NCBI
2	Assassi S, Reveille JD, Arnett FC, Weisman MH, Ward MM, Agarwal SK, Gourh P, Bhula J, Sharif R, Sampat K, et al: Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4–5. J Rheumatol. 38:87–98. 2011. View Article : Google Scholar
3	El Maghraoui A: Extra-articular manifestations of ankylosing spondylitis: Prevalence, characteristics and therapeutic implications. Eur J Intern Med. 22:554–560. 2011. View Article : Google Scholar : PubMed/NCBI
4	Smith JA: Update on ankylosing spondylitis: Current concepts in pathogenesis. Curr Allergy Asthma Rep. 15:4892015. View Article : Google Scholar
5	Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Dilthey A, Pirinen M, Stone MA, et al: Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 43:761–767. 2011. View Article : Google Scholar : PubMed/NCBI
6	Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, Sun L, Wang N, Han J, Han H, et al: Association of STAT3 and TNFRSF1A with ankylosing spondylitis in han chinese. Ann Rheum Dis. 70:289–292. 2011. View Article : Google Scholar
7	Wright MW and Bruford EA: Naming 'junk': Human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics. 5:90–98. 2011. View Article : Google Scholar : PubMed/NCBI
8	Xie Z, Li J, Wang P, Li Y, Wu X, Wang S, Su H, Deng W, Liu Z, Cen S, et al: Differential expression profiles of long noncoding RNA and mRNA of osteogenically differentiated mesenchymal stem cells in ankylosing spondylitis. J Rheumatol. 43:1523–1531. 2016. View Article : Google Scholar : PubMed/NCBI
9	Li X, Chai W, Zhang G, Ni M, Chen J, Dong J, Zhou Y, Hao L, Bai Y and Wang Y: Down-regulation of lncRNA-AK001085 and its influences on the diagnosis of ankylosing spondylitis. Med Sci Monit. 23:11–16. 2017. View Article : Google Scholar : PubMed/NCBI
10	Wang H, Zhao J, Zhang H, Huang Y, Wang S, Tu Q and Yang N: CARD11 blockade suppresses murine collagen-induced arthritis via inhibiting CARD11/Bcl10 assembly and T helper type 17 response. Clin Exp Immunol. 176:238–245. 2014. View Article : Google Scholar : PubMed/NCBI
11	Mahurkar S, Moldovan M, Suppiah V and O'Doherty C: Identification of shared genes and pathways: A comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment. PLoS One. 8:e576552013. View Article : Google Scholar : PubMed/NCBI
12	O'Brien SA, Zhu M and Zhang W: The importance of IL-6 in the development of LAT-mediated autoimmunity. J Immunol. 195:695–705. 2015. View Article : Google Scholar : PubMed/NCBI
13	Aslani S, Mahmoudi M, Garshasbi M, Jamshidi AR, Karami J and Nicknam MH: Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol. 35:2723–2731. 2016. View Article : Google Scholar : PubMed/NCBI
14	Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
15	Jiang W, Liu Y, Liu R, Zhang K and Zhang Y: The lncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression. Cell Rep. 11:137–148. 2015. View Article : Google Scholar : PubMed/NCBI
16	Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z, Zhi H, Wang T, Guo Z and Li X: Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489. 2015. View Article : Google Scholar : PubMed/NCBI
17	Fei Q, Bai X, Lin J, Meng H, Yang Y and Guo A: Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis. Int J Mol Med. 41:3537–3550. 2018.PubMed/NCBI
18	Chen WC, Wei CC, Lu HF, Wong HS, Woon PY, Hsu YW, Huang JD and Chang WC: rs657075 (CSF2) is associated with the disease phenotype (BAS-G) of ankylosing spondylitis. Int J Mol Sci. 18:E832017. View Article : Google Scholar : PubMed/NCBI
19	Wang L, Chen Z, An L, Wang Y, Zhang Z, Guo Y and Liu C: Analysis of long non-coding RNA expression profiles in non-small cell lung cancer. Cell Physiol Biochem. 38:2389–2400. 2016. View Article : Google Scholar : PubMed/NCBI
20	Peng W and Jiang A: Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer. Biomed Pharmacother. 83:712–717. 2016. View Article : Google Scholar : PubMed/NCBI
21	Hirano T, Yoshikawa R, Harada H, Harada Y, Ishida A and Yamazaki T: Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression. Mol Cancer. 14:902015. View Article : Google Scholar : PubMed/NCBI
22	Wang S, Hui Y, Li X and Jia Q: Silencing of lncRNA-CCDC26 restrains the growth and migration of glioma cells in vitro and in vivo via targeting miR-203. Oncol Res. 26:1143–1154. 2018. View Article : Google Scholar
23	Xu H, Liew LN, Kuo IC, Huang CH, Goh DL and Chua KY: The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology. 125:218–228. 2010. View Article : Google Scholar
24	Huan J, Kaler LJ, Mooney JL, Subramanian S, Hopke C, Vandenbark AA, Rosloniec EF, Burrows GG and Offner H: MHC class II derived recombinant T Cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis. J Immunol. 180:1249–1257. 2008. View Article : Google Scholar : PubMed/NCBI
25	Landers-Ramos RQ, Sapp RM, Jenkins NT, Murphy AE, Cancre L, Chin ER, Spangenburg EE and Hagberg JM: Chronic endurance exercise affects paracrine action of CD31⁺ and CD34+ cells on endothelial tube formation. Am J Physiol Heart Circ Physiol. 309:H407–H420. 2015. View Article : Google Scholar : PubMed/NCBI
26	Azizi E, Massoud A, Amirzargar AA, Mahmoudi M, Soleimanifar N, Rezaei N, Jamshidi AR, Nikbin B and Nicknam MH: Association of CTLA4 gene polymorphism in Iranian patients with ankylosing spondylitis. J Clin Immunol. 30:268–271. 2010. View Article : Google Scholar
27	Yang PT, Kasai H, Zhao LJ, Xiao WG, Tanabe F and Ito M: Increased CCR4 expression on circulating CD4(+) T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 138:342–347. 2004. View Article : Google Scholar : PubMed/NCBI
28	Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D and Romero P: Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 58:2307–2317. 2008. View Article : Google Scholar : PubMed/NCBI
29	Keir ME, Butte MJ, Freeman GJ and Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 26:677–704. 2008. View Article : Google Scholar : PubMed/NCBI
30	Shinohara T, Taniwaki M, Ishida Y, Kawaichi M and Honjo T: Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. 23:704–706. 1994. View Article : Google Scholar : PubMed/NCBI
31	Bertin J, Wang L, Guo Y, Jacobson MD, Poyet JL, Srinivasula SM, Merriam S, DiStefano PS and Alnemri ES: CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem. 276:11877–11882. 2001. View Article : Google Scholar : PubMed/NCBI
32	Chabaud M, Fossiez F, Taupin JL and Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 161:409–414. 1998.PubMed/NCBI
33	Maddur MS, Miossec P, Kaveri SV and Bayry J: Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 181:8–18. 2012. View Article : Google Scholar : PubMed/NCBI
34	Yan P, Luo S, Lu JY and Shen X: Cis- and trans-acting lncRNAs in pluripotency and reprogramming. Curr Opin Genet Dev. 46:170–178. 2017. View Article : Google Scholar : PubMed/NCBI
35	Pian L, Wen X, Kang L, Li Z, Nie Y, Du Z, Yu D, Zhou L, Jia L, Chen N, et al: Targeting the IGF1R pathway in breast cancer using antisense lncRNA-mediated promoter cis competition. Mol Ther Nucleic Acids. 12:105–117. 2018. View Article : Google Scholar : PubMed/NCBI
36	Lipovich L: Abstract IA3: Regulatory networks in onco-lncRNAomics: Cis-regulation and non-conservation. Indian J Microbiol. 52:400–405. 2012.